You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Selumetinib, Differentiated Thyroid Cancer , AZD6244

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +6 more
  • Ipilimumab
  • +4 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Dec 12, 2022

Gastric Cancer, Cancer of Stomach, Gastric Adenocarcinoma Trial in Woodville South (IMU-131, Irinotecan or Paclitaxel,

Not yet recruiting
  • Gastric Cancer
  • +5 more
  • IMU-131
  • +2 more
  • Woodville South, South Australia, Australia
    The Queen Elizabeth Hospital
Apr 12, 2022

Esophageal Cancer, Squamous Cell Esophagus Cancer, Adenocarcinoma Esophagus Trial in Boston (Pembrolizumab)

Active, not recruiting
Has Results
  • Esophageal Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Apr 7, 2022

Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

Not yet recruiting
  • Metastatic Breast Cancer
  • +4 more
  • CDK 4/6 inhibitors
  • Endocrine therapy
  • Helsinki, Finland
  • +11 more
Sep 19, 2023

Breast Cancer Trial in Denver, Sarasota, Nashville (AC682)

Recruiting
  • Breast Cancer
  • Denver, Colorado
  • +4 more
Dec 12, 2022

Solid Tumors Trial (TCR-T cells, Fludarabine, Cyclophosphamide Capsules)

Not yet recruiting
  • Solid Tumors
  • TCR-T cells
  • +4 more
  • (no location specified)
Dec 12, 2022

Recurrent Glioblastoma Trial in San Francisco (Individualized therapy)

Recruiting
  • Recurrent Glioblastoma
  • Individualized therapy
  • San Francisco, California
    University of California San Francisco
Nov 2, 2021

Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Palo Alto (68Ga-PSMA-11, Magnetic resonance imaging

Completed
Has Results
  • Stage II Prostate Adenocarcinoma
  • Stage III Prostate Adenocarcinoma
  • Palo Alto, California
    Stanford University, School of Medicine
Mar 2, 2022

Estrogen Levels Among Breast Cancer Patients Trial in Tucson (Estradiol)

Completed
Has Results
  • Estrogen Levels Among Breast Cancer Patients
  • Tucson, Arizona
    University of Arizona
Feb 3, 2022

Prehabilitation, Pancreas Cancer, Surgery Trial in Netherlands (Preoperative optimisation program)

Not yet recruiting
  • Prehabilitation
  • +3 more
  • Preoperative optimisation program
  • Amsterdam, Netherlands
  • +14 more
May 1, 2023

Cervical Carcinoma, Chemoradiotherapy, Anti-programmed Cell Death Receptor 1 Trial in Beijing (Camrelizumab plus Concurrent

Recruiting
  • Cervical Carcinoma
  • +8 more
  • Camrelizumab plus Concurrent chemoradiotherapy
  • Beijing, Beijing, China
    Lei Li
Apr 5, 2022

Breast Cancer, Solid Tumor Trial in Shanghai (BL-B01D1)

Recruiting
  • Breast Cancer
  • Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Jul 20, 2022

Metastatic Pancreatic Cancer, Advanced Pancreatic Cancer Trial in Lyon (Tumor samples (archival FFPE) and blood samples)

Recruiting
  • Metastatic Pancreatic Cancer
  • Advanced Pancreatic Cancer
  • Tumor samples (archival FFPE) and blood samples
  • Lyon, France
    Centre Léon Bérard
Jul 21, 2022

Three Radiation Techniques for Hypofractionated Whole Breast

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    May 24, 2022

    Breast Cancer Trial in Zhengzhou (Hetrombopag, rh-TPO)

    Not yet recruiting
    • Breast Cancer
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    May 26, 2022

    Chemo-induced Peripheral Neuropathy, Cancer Trial in Los Angeles (Qi Gong)

    Terminated
    • Chemotherapy-induced Peripheral Neuropathy
    • Cancer
    • Qi Gong
    • Los Angeles, California
      Cedars Sinai Medical Center
    Sep 28, 2022

    Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

    Recruiting
    • Deleterious BRCA1 Gene Mutation
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 23, 2022

    Solid Tumor Trial in United States (OBT076, a CD205-directed antibody-drug conjugate)

    Recruiting
    • Solid Tumor
    • OBT076, a CD205-directed antibody-drug conjugate
    • Los Angeles, California
    • +5 more
    Jan 10, 2022

    Head and Neck Early Relapse Detection Study (HERD)

    Not yet recruiting
    • Head and Neck Cancer
      • (no location specified)
      Jul 28, 2022

      Postoperative Analgesia, Hand Strength, Health Related Quality of Life Trial (Diclofenac Sodium, Levobupivacaine bolus

      Completed
      • Postoperative Analgesia
      • +6 more
      • Diclofenac Sodium
      • +2 more
      • (no location specified)
      Apr 26, 2023

      HER2-positive Breast Cancer Trial in Nanjing (Pyrotinib)

      Recruiting
      • HER2-positive Breast Cancer
      • Nanjing, Jiangsu, China
        JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
      Apr 26, 2023

      Obstructive Sleep Apnea, Lung Cancer Trial in Ankara (STOP- BANG Questionnaire and Epworth sleepiness scale)

      Completed
      • Obstructive Sleep Apnea
      • Lung Cancer
      • STOP- BANG Questionnaire and Epworth sleepiness scale
      • Ankara, Turkey
        Atatürk Chest Diseases and Chest Surgery Training and Research H
      Jan 3, 2022

      Within Postoperative Wound-Healing Microenvironment in

      Recruiting
      • GastroEsophageal Cancer
      • prospective collection of surgical exudates (SEs)
      • Fairfax, Virginia
        Inova Schar Cancer Institute
      Jul 29, 2022

      Ovarian Cancer Trial in Worldwide (Olaparib, Placebo)

      Completed
      • Ovarian Cancer
      • Graz, Austria
      • +162 more
      Aug 1, 2022

      The Young Women's Breast Cancer Study

      Active, not recruiting
      • Breast Cancer
        • Aurora, Colorado
        • +12 more
        Dec 14, 2021